4//SEC Filing
KOSKI ROBERT C 4
Accession 0001493152-22-035570
CIK 0001174940other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:15 PM ET
Size
6.6 KB
Accession
0001493152-22-035570
Insider Transaction Report
Form 4
ORAGENICS INCOGEN
KOSKI ROBERT C
Director10% Owner
Transactions
- Sale
Common Stock
2022-12-14$0.17/sh−4,503$788→ 1,310,149 total(indirect: See footnote)
Holdings
- 212,839
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
- [F3]Shares owned directly by Robert C. Koski, a director of the Company. An aggregate of 53,086 shares held by individual trusts for reporting person's five children and previously reflected as part of reporting person's indirect beneficial ownership have been excluded from the reporting person's beneficial ownership as the reporting person no longer serves as trustee for the trusts.
Documents
Issuer
ORAGENICS INC
CIK 0001174940
Entity typeother
Related Parties
1- filerCIK 0001234880
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:15 PM ET
- Size
- 6.6 KB